![Anthony P. Jansz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anthony P. Jansz
Directeur/Bestuurslid bij The Medical Finance Co.
Actieve functies van Anthony P. Jansz
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
The Medical Finance Co. | Directeur/Bestuurslid | - | - |
Loopbaan van Anthony P. Jansz
Eerdere bekende functies van Anthony P. Jansz
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
EnteroMedics, Inc.
![]() EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | Directeur/Bestuurslid | 11-05-2011 | 12-08-2016 |
Independent Dir/Board Member | 01-05-2011 | 14-04-2015 | |
The Australian Institute of Weight Control | Voorzitter | 01-03-2011 | 01-03-2011 |
THE CARLYLE GROUP INC. | Corporate Officer/Principal | 01-01-2000 | 01-01-2005 |
Statistieken
Internationaal
Verenigde Staten | 3 |
Australië | 3 |
Operationeel
Director/Board Member | 2 |
Independent Dir/Board Member | 1 |
Chairman | 1 |
Sectoraal
Health Technology | 2 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
THE CARLYLE GROUP INC. | Finance |
Bedrijven in privébezit | 3 |
---|---|
EnteroMedics, Inc.
![]() EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | Health Technology |
The Australian Institute of Weight Control | |
The Medical Finance Co. |
- Beurs
- Insiders
- Anthony P. Jansz
- Ervaring